The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.
暂无分享，去创建一个
H. Gendelman | J. McMillan | T. Wysocki | Gang Zhang | H. Gelbard | P. Ciborowski | B. Wysocki | P. Dash | J. Wiederin | S. Gorantla | L. Poluektova | N. Haverland | Xin-ming Liu | M. Araínga | Dongwei Guo | V. Goodfellow | A. Martinez-Skinner | Jaclyn S. Knibbe-Hollinger